Camilla Kloss Fenneberg

Overview

Camilla Kloss Fenneberg is the Chief Executive Officer and an investor in sustainable biotechnology companies. She leads EvodiaBio, a Copenhagen-based firm specializing in producing natural, sustainable aromas for the food and beverage industry. Under her leadership, EvodiaBio has developed a groundbreaking yeast-based technology that enables the production of natural aromas, enhancing the taste of non-alcoholic beverages while reducing resource consumption and CO₂ emissions. EvodiaBio's innovative approach has attracted significant investment, including a €6 million funding round in December 2025, led by RA Capital Management’s Planetary Health Fund and joined by other investors such as Wild Radicals and Francis Family Funds. This capital is intended to accelerate the company's growth in existing markets and support its expansion into Asia. The funding round also saw participation from existing investors like EIFO, Ananke Ventures, Newtree Impact, and PINC (Paulig), as well as board members and co-founders. In recognition of her contributions to the biotech industry, Camilla Kloss Fenneberg was awarded the EY Entrepreneur of the Year 2024 title in the Life Sciences category for Denmark. This accolade reflects her dedication to advancing sustainable and innovative solutions in the biotechnology sector, underscoring her role as a key figure in promoting green transition and environmental sustainability through industrial biotech innovations.

Investment Focus

• Sustainable and innovative biotech solutions
• Scalable business models
• Global market potential
• Experienced management teams
• Commitment to environmental sustainability

Portfolio Companies